A 7-month inhalation toxicology study in C57BL/6 mice demonstrates reduced pulmonary inflammation and emphysematous changes following smoking cessation or switching to e-vapor products
Ashutosh Kumar(Altria (United States)), K. Monica Lee(Altria (United States)), Manuel C. Peitsch(Philip Morris International (Switzerland)), Céline Merg(Philip Morris International (Switzerland)), Nikolai V. Ivanov(Philip Morris International (Switzerland)), Athanasios Kondylis(Philip Morris International (Switzerland)), Bjoern Titz(Roche (Switzerland)), Emmanuel Guedj(Philip Morris International (Switzerland)), Amit Gupta(University of Washington), Ulrike Kogel(Philip Morris International (Switzerland)), Josh Allen(Battelle), Julia Hoeng(Philip Morris International (Switzerland)), Yang Xiang(Wuhan University), Anthony Skowronek(Battelle), Marja Talikka(Philip Morris International (Switzerland))
Cited by 7
Related Papers
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
|Nature|2011|1.4k
Predicting cancer outcomes with radiomics and artificial intelligence in radiology
|Nature Reviews Clinical Oncology|2021|810
Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
|Cancer Immunology Research|2019|313
Inhalation Toxicity and Lung Toxicokinetics of C60 Fullerene Nanoparticles and Microparticles
|Toxicological Sciences|2007|201
Induction of Inflammasome-dependent Pyroptosis by Carbon Black Nanoparticles
|Journal of Biological Chemistry|2011|188